IRIS UniCatt

Sgalla, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 861
EU - Europa 769
AS - Asia 500
SA - Sud America 138
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 849
SG - Singapore 215
SE - Svezia 194
IT - Italia 154
CN - Cina 139
BR - Brasile 132
DE - Germania 97
IE - Irlanda 62
FR - Francia 57
PL - Polonia 45
ID - Indonesia 43
RU - Federazione Russa 41
GB - Regno Unito 34
KR - Corea 25
IN - India 22
AT - Austria 20
FI - Finlandia 20
HK - Hong Kong 14
BE - Belgio 13
IR - Iran 11
UA - Ucraina 11
CA - Canada 7
VN - Vietnam 6
EG - Egitto 5
RO - Romania 5
TR - Turchia 5
LT - Lituania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
CI - Costa d'Avorio 3
MA - Marocco 3
AR - Argentina 2
CZ - Repubblica Ceca 2
ES - Italia 2
IQ - Iraq 2
LV - Lettonia 2
MX - Messico 2
PY - Paraguay 2
SA - Arabia Saudita 2
AL - Albania 1
AU - Australia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EU - Europa 1
IL - Israele 1
JO - Giordania 1
LK - Sri Lanka 1
MK - Macedonia 1
NL - Olanda 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 2.284
Salva come PNG Salva come JPEG
Città #
Chandler 207
Singapore 160
Rome 63
Dublin 62
Ashburn 50
The Dalles 50
Jakarta 43
Milan 43
Warsaw 40
San Mateo 32
Princeton 29
Fairfield 28
Beijing 26
Moscow 26
Boston 23
Ann Arbor 22
Hefei 19
North Bergen 19
Wilmington 19
Nuremberg 18
Munich 17
New York 17
Seoul 17
Frankfurt am Main 16
Woodbridge 16
Helsinki 15
Düsseldorf 14
Los Angeles 12
Vienna 12
Hong Kong 11
Brussels 10
Bremen 9
Kish 9
London 9
Portsmouth 9
Augusta 8
Boardman 8
Jacksonville 8
Lauterbourg 8
Houston 7
Marseille 7
Pune 7
São Paulo 7
Brasília 6
Santa Clara 6
Belo Horizonte 5
Cambridge 5
Chicago 5
Falkenstein 5
Nanjing 5
Norwalk 5
Redwood City 5
Toronto 5
Council Bluffs 4
Fortaleza 4
Guangzhou 4
Shanghai 4
Washington 4
Abidjan 3
Atlanta 3
Boulder 3
Caxias do Sul 3
Central 3
Dong Ket 3
Dubai 3
Fremont 3
Hammond 3
Lappeenranta 3
Lodz 3
Mumbai 3
Pavia 3
San Francisco 3
Seattle 3
Stockholm 3
Tashkent 3
Andover 2
Ankara 2
Aracaju 2
Areannamkwaengi 2
Asunción 2
Bani Suwayf 2
Brno 2
Brooklyn 2
Cairo 2
Coimbatore 2
Cuneo 2
Diadema 2
Edinburgh 2
Ganzhou 2
Goiânia 2
Guarujá 2
Guarulhos 2
Hanoi 2
Hyderabad 2
Itajaí 2
Juiz de Fora 2
Leawood 2
Lucknow 2
Manassas 2
Monmouth Junction 2
Totale 1.405
Salva come PNG Salva come JPEG
Nome #
Digital lung auscultation: Will early diagnosis of fibrotic interstitial lung disease become a reality? 99
Residual respiratory impairment after COVID-19 pneumonia 96
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: Relationships with disease progression and pulmonary function trends 84
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease 79
Residual respiratory impairment after COVID-19 pneumonia 78
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 75
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study 74
Antibody-based therapies for idiopathic pulmonary fibrosis 68
Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don't 67
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach 66
Progressive Fibrosing Interstitial Lung Disease A Proposed Integrated Algorithm for Management 64
Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study 63
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis 62
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis 62
Reply to: Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj 58
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF) 57
Antibody-based therapies for idiopathic pulmonary fibrosis 56
Advances with pharmacotherapy for the treatment of interstitial lung disease 56
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal? 55
Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis 54
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 53
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis 52
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis 51
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia 50
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management 48
Do randomized clinical trials always provide certain results? 47
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials 46
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond 44
Phase three clinical trials in idiopathic pulmonary fibrosis 43
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis 43
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study 41
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials? 41
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions 40
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study 39
Promising advances in treatments for the management of idiopathic pulmonary fibrosis 36
Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis) 35
Role of Stenotrophomonas maltophilia isolation in patients with non CF bronchiectasis 34
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis 34
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study 32
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey 30
Update in pulmonary fibrosis 2018 27
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filter 21
Pharmacological treatment of idiopathic pulmonary fibrosis: Time to step out of the comfort zone? 20
X-ray Micro-Computed Tomography for Nondestructive Three-Dimensional (3D) X-ray Histology 16
COVID-related fibrosis: insights into potential drug targets 16
“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease 13
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 10
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis 9
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series 4
Totale 2.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 0 8
2020/2021116 7 8 1 11 5 9 16 18 9 13 11 8
2021/2022268 21 9 4 27 9 11 2 55 15 8 57 50
2022/2023558 60 69 41 87 48 54 18 42 77 34 18 10
2023/2024389 13 82 13 23 16 31 25 14 19 45 55 53
2024/2025935 36 12 92 54 84 35 53 49 126 121 238 35
Totale 2.348